Titel | Introducing Ruthenium Brachytherapy in UZ Leuven |
Abstract Nr. | 3015 |
Doel | To introduce Ruthenium Brachytherapy at the UZ Leuven hospitals to improve the local treatment of uveal and conjunctival ocular tumors. |
Methodes | Ruthenium brachytherapy has been used for 3 decades now in European ocular oncology centers, to treat small and middle sized melanomas. Building on these experiences, we introduce this state-of-the-art treatment with local recurrence of 5% and limited radiation retinopathy. |
Resultaten | The implications for treatment of Ruthenium brachytherapy, with a longer hospital stay than Strontium brachytherapy, follow-up, and safety protocols will be discussed in the presentation. |
Conclusie | Introducing Ruthenium brachytherapy in Belgium for the treatment of ocular tumors, expands the range of tumors that can be treated locally, with a minimum of complications. |
Belangenverstrengeling | Nee |
Naam | MISSOTTEN |
Initialen | G |
Instituut | Dept Ophthalmology, Catholic University Leuven |
Stad | Leuven |
Naam | Van Ginderdeuren |
Initialen | R |
Instituut | Dept Ophthalmology, Catholic University Leuven |
Stad | Leuven |
Naam | Clément |
Initialen | P |
Instituut | Dept Medical Oncology, Catholic University Leuven |
Stad | Leuven |
Naam | Vanden Bempt |
Initialen | I |
Instituut | Dept Medical Genetics, Catholic University Leuven |
Stad | Leuven |
Naam | Van Limbergen |
Initialen | E |
Instituut | Dept Radiotherapy, Catholic University Leuven |
Stad | Leuven |
Naam | Van Calster |
Initialen | J |
Instituut | Dept Ophthalmology, Catholic University Leuven |
Stad | Leuven |